Skip to Main Content

NISH (NITAG Support Hub) 3: Malaria vaccines: Nigeria

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the RTS,S/AS01 malaria vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Malaria vaccines

Dzi K. T. J. (2023). Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and GhanaFrontiers in public health11, V DOI: 10.3389/fpubh.2023.1237011

Ajayi, M. Y., & Emeto, D. C. (2023). Awareness and acceptability of malaria vaccine among caregivers of under-5 children in Northern NigeriaMalaria journal22(1), 329. DOI: 10.1186/s12936-023-04768-z

Sulaiman, S.K., Tsiga-Ahmed, F.I.I., Musa, M.S., Sulaiman, A.K., Dayyab, F.M., Khan, M.A., Ahmad, S.I., Akpan, U.A.O., Usman, U.I. and Bako, A.T., 2023. Prevalence, determinants, and reasons for malaria vaccine hesitancy among caregivers of under-five children in Nigeria: Results from a nationwide cross-sectional survey. Vaccine41(8), pp.1503-1512. (Not OA)